Vous avez cherché: performance status (Anglais - Danois)

performance status
ressource- opsætning

performance status and bmi
performance-status og bmi

weight, performance status
vægt, performancestatus

ecog performance status, n (%)
ecog performance status n (%)

patients with poor performance status
patienter med lav performance status

performance status and co-morbidities
performancestatus og komorbiditet

view tasks performance status information
vis information om opgavepræstation

baseline ecog performance status (ps) = 0
ecog performance status (ps)= 0 ved baseline

patients with performance status 2 to 4
patienter med funktionsstatus 2 til 4

all patients had a baseline ecog performance status of 0 or 1.
alle patienter havde en ecog-performancestatus ved baseline på 0 eller 1.

karnofsky index, a measure of your general performance status.
karnofsky index, et mål for deres generelle velbefindende

all patients included in this study had an ecog performance status 0 or 1.
alle patienter, der var inkluderet i dette studie havde en funktionsstatus for ecog på 0 eller 1.

only patients with ecog performance status 0 and 1 were enrolled in study go28141.
kun patienter med ecog-performancestatus 0 og 1 blev inkluderet i studie go28141.

87% of patients enrolled had an ecog performance status score of 0-1.
87 % af de inkluderede patienter havde en ecog-score på 0-1.

age, gender and who performance status had no effect on the pharmacokinetics of rituximab.
alder, køn, race og who performance status havde ingen effekt på rituximabs farmakokinetik.

clinical trials excluded patients with ecog performance status > 1 and mucosal melanoma.
i kliniske forsøg blev patienter med ecog performance status >1 og mucosalt melanom ekskluderet.

patients with performance status (ps) 2 or higher were excluded from clinical studies.
patienter med performance status (ps) 2 eller derover var ekskluderet fra kliniske studier.

a positive benefit- risk balance has not been documented in patients with ecog 2 performance status.
der er ikke dokumenteret en positiv fordel/risikobalance hos patienter med ecog-performance-status 2.

only patients with eastern cooperative oncology group (ecog) performance status 0 or 1 were eligible.
kun patienter, som havde eastern cooperative oncology group (ecog)-performancestatus 0 eller 1 kunne deltage.

the ecog performance status was comparable between both groups, as was the number and type of prior therapies.
ecog-(eastern cooperative oncology group)-performance-status var næsten ens for begge grupper, hvilket også gjaldt for antallet og typen af tidligere behandlinger.